Effect of modified ShengYangYiwei decoction on painless gastroscopy and gastrointestinal and immune function in gastric cancer patients

Table 1 Comparison of the general data between the two patient groups

Group	Sex		ASA classify		Median age (age)
	Man	Woman	I level	II level
Treatment group (n = 56)	32	24	44	12	36 (20-66)
Control group (n = 50)	26	24	42	8	41 (19-61)
χ2/t value	0.564		0.218		0.461
P value	> 0.05		> 0.05		> 0.05

ASA: American Society of Anesthesiologist.

Table 2 Comparison of gastroscopy in the two groups

Group	Operation time (min)	Wakeup time (min)	Self-ambulation time (min)	Total dose of propofol (mg)
Treatment group (n = 56)	4.43 ± 2.41	3.36 ± 0.27	6.02 ± 0.26	115.36 ± 8.17
Control group (n = 50)	4.35 ± 2.33	6.71 ± 0.34	7.68 ± 0.61	146.21 ± 10.17
t value	0.497	4.215	3.234	3.213
P value	> 0.05	< 0.01	< 0.05	< 0.01

Table 3 Comparison of complications between the two groups during anaesthesia, n (%)

Group	Hypoxemia	Hypotension	Hiccup	F value	P value
Treatment group (n = 56)	6 (10.71)	22 (10.54)	3 (5.36)	17.19	< 0.05
Control group (n = 50)	10 (20)	15 (30.00)	6 (12.00)

Table 4 Comparison of gastrointestinal reactions between the two groups after examination, n (%)

Group	Nausea	Vomiting	Abdominal distension	Abdominal pain	F value	P value
Treatment group (n = 56)	10 (17.86)	4 (7.14)	8 (14.29)	4 (7.14)	11.78	< 0.05
Control group (n = 50)	13 (26.00)	8 (16.00	13 (26.00)	6 (12.00)

Table 5 Comparison of immune cell values in T0, T1 and T2 between the two groups (%), mean ± SD

Group	CD4+			CD8+			NK cell
	T0	T1	T2	T0	T1	T2	T0	T1	T2
Treatment group (n = 56)	40.65 ± 6.73	37.16 ± 5.78a,b	33.75 ± 5.36a,c	25.91 ± 6.25	22.35 ± 5.49a,b	21.03 ± 4.35a,c	14.54 ± 1.34	16.61 ± 1.80a,b	20.74 ± 1.77a,c
Control group (n = 50)	41.56 ± 7.19	35.19 ± 6.31a	29.09 ± 5.63a	26.15 ± 5.58	21.11 ± 4.74a	18.49 ± 4.56a	14.40 ± 1.34	21.79 ± 1.45a	26.81 ± 1.39a

^aP < 0.05 vs T0.

^bP < 0.05 vs controls with T1.

^cP < 0.05 vs controls with T2. NK: Natural killer.

Table 6 Comparison of inflammatory indicators in T0, T1 and T2 between the two groups, mean ± SD

Group	IL-6 (pg/mL)			TNF-α (ng/L )
	T0	T1	T2	T0	T1	T2
Treatment group (n = 56)	50.18 ± 9.05	109.58 ± 14.95a,b	70.81 ± 9.50a,c	9.63 ± 2.17	12.53 ± 2.27a,b	10.48 ± 3.48a,c
Control group ( n = 50)	49.06 ± 9.41	128.64 ± 18.61a	89.61 ± 9.41a	9.70 ± 1.99	16.28 ± 3.74a	14.62 ± 3.57a

^aP < 0.05 versus T0.

^bP < 0.05 compared to controls with T1.

^cP < 0.05 compared to controls with T2. TNF-α: Tumor necrosis factor-alpha.